Biotech · Private company
Recross Cardio, Inc.
Track this companyFree. Adds Recross Cardio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Recross P3 Occluder (P3O) SystemPFOClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO StudyNA · RECRUITING · started Oct 9, 2025ClinicalTrials.gov NCT07172464 · fetched Nov 12, 2026